v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
OPERATING ACTIVITIES:    
Net loss $ (134) $ (509,366)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 76,565 74,880
Non-cash impairment charges 0 511,365
Deferred income tax provision (benefit) (3,007) (46,663)
Share-based compensation 11,009 7,165
Amortization of debt issuance costs and expenses associated with debt refinancing 2,015 3,275
Non-cash lease adjustment 2,948 (599)
Loss on disposal of property and equipment 733 494
Change in fair value of contingent consideration and others (774) (203)
Changes in assets and liabilities:    
Accounts receivable 10,604 (6,540)
Inventories (3,855) (20,074)
Prepaid expenses and other current assets (29,317) (21,216)
Other non-current assets 389 2,334
Accounts payable, accrued expenses and other current liabilities (34,384) (2,078)
Contract liabilities (1,392) 2,344
Other non-current liabilities 1,205 2,544
Net cash provided by (used in) operating activities 32,605 (2,338)
INVESTING ACTIVITIES:    
Purchases of property and equipment (27,155) (49,066)
Purchases of short-term investments (30,976) (8,502)
Net cash used in investing activities (58,131) (57,568)
FINANCING ACTIVITIES:    
Proceeds from borrowings of long-term indebtedness 75,900 67,300
Payments on debt (60,475) (31,131)
Payment of debt issuance costs (275) (3,855)
Purchases of treasury stock 0 (221)
Payments for contingent considerations (6,842) (16,451)
Proceeds from exercised stock options and employee stock purchase plan 760 957
Cash taxes paid in net equity settlement (1,589) (2,361)
Net cash provided by financing activities 7,479 14,238
Effect of exchange rate changes on cash and cash equivalents (2,586) 17,207
Net decrease in cash and cash equivalents (20,633) (28,461)
Cash and cash equivalents at beginning of period 235,048 246,375
Cash and cash equivalents at end of period $ 214,415 $ 217,914